Curaleaf Holdings CEO Joseph Lusardi is ecstatic about the company’s record-setting, $400 million USD equity raise and recent listing on the CSE. Curaleaf operates in the United States, is a fully vertical medical cannabis operator, and sells 90 percent of what the company cultivates and produces in its dispensaries. The company will be operating in 12 states by the end of 2018 and is licensed to open 69 dispensaries nation-wide. Curaleaf’s largest footprint is in Florida, where it already has a strong delivery presence and 13 dispensaries, with plans to open 22 more stores in the coming months. Lusardi supports the STATES Act because it would open up banking and debt markets to US cannabis companies.
Related Articles → See More
-
Not an average greenhouse at NC State University
-
Heavy rain disrupts cannabis season as farmers seek April extension for beldia crop
-
Smart root zone monitoring in stone wool cultivation
-
Staff turnover and process consistency: a growing challenge for European cannabis operators
-
Leveraging soil science for commercial outdoor success
-
Researchers identify optimal magnesium levels, finding different responses than N, P, and K
-
NL: Origins of THC, CBD and CBC in cannabis revealed
-
Data collection as an operational tool in commercial cannabis cultivation
-
Genetic selection as a trade off driven process
-
As margins tighten, cannabis compliance tools face a usability test